On April 19, under the guidance of the Shanghai Stock Exchange, Penghua Fund held an in-depth visit to Taiji Group of the Shanghai Stock Exchange's "I am a shareholder" and the beauty of Penghua Fund's fundamental investment, the quintessence of ETF investment and education series in Chongqing. This event is one of the series of activities of Penghua Fund's "Beauty of Fundamental Investment", and it is also the fifth stop of Penghua Guoqu ETF investment and education into listed Chinese medicine companies, and it is also an important measure for Penghua Fund to jointly build an "investment and education consortium" with the investment and education base of Galaxy Securities, Huatai Securities and other securities companies to promote the high-quality development of the Chinese medicine industry and vigorously promote the quintessence of culture. Jiang Qian, Deputy General Manager and Secretary of the Board of Directors of Taiji Group, Xu Wang, Director of Securities and Investment Department and Representative of Securities Affairs, Yu Lingbo, General Manager of Brand Management Department of Penghua Fund, Zhang Yuxiang, Fund Manager of Quantitative and Derivatives Investment Department, Ruan Wen, Pharmaceutical Analyst of Southwest Securities, and other guests and institutional partners participated in the visit.
As an asset management institution with a high sense of social responsibility, Penghua Fund has always attached great importance to investor education, constantly innovated the investment education model, and hoped to let investors experience a beautiful investment process through a series of innovative, interesting and characteristic investment education content. As an investment education carrier of "learning traditional culture and improving investment literacy", Penghua Guoqu ETF Investment Education Ecology hopes to lead investors to find investment wisdom from traditional Chinese culture, understand the way of investment and financial management, and enhance investment confidence.
In the sharing of Xu Wang, Director of the Securities and Investment Department and Securities Affairs Representative of Taiji Group, investors had an in-depth understanding of the development process of Taiji Group. Founded in 1972, Taiji Group is a holding and investment enterprise of China National Pharmaceutical Group Co., Ltd., one of the "world's top 500". As an important part of the modern Chinese medicine sector of Sinopharm Group, the company is committed to inheriting and innovating traditional Chinese medicine and developing modern medicine.
During the event, Zhang Yuxiang, fund manager of the quantitative and derivatives investment department of Penghua Fund, gave an outlook on the investment in the traditional Chinese medicine sector in 2024. On the one hand, the supply-side, payment-side, demand-side and other aspects of the policy continue to be good, and gradually implement the cash; on the other hand, the mixed reform of state-owned enterprises in the traditional Chinese medicine industry and the improvement of corporate governance are accelerating, and the equity incentive is worth looking forward toThe provincial standard is expected to accelerate the promotion, and a new round of adjustment of the basic drug catalogue is about to be implemented, and the relevant varieties of traditional Chinese medicine in the catalogue are expected to accelerate the layout of the hospital. From the perspective of valuation, the overall valuation of the current traditional Chinese medicine industry is low and has entered a better allocation range.
Ruan Wen, a pharmaceutical analyst at Southwest Securities, mainly analyzed the investment logic and investment direction of the traditional Chinese medicine sector. In Ruan Wen's view, the current traditional Chinese medicine sector is in a continuous favorable policy, valuation and holdings are close to the bottom, and the company's performance has entered a reversal stage, ushering in a better investment opportunity. Three directions for the whole year of 2024 are worth paying attention to: first, the adjustment of the basic drug catalogue brings new opportunities for the development of traditional Chinese medicine, second, the recovery of traditional Chinese medicine consumer goods after the epidemic, and we are optimistic about the price increase and volume of branded traditional Chinese medicine; third, the targets related to the mixed reform of state-owned enterprises and the targets with high dividends have certain defensive attributes.
As a representative of inclusive finance and a professional asset management institution, public funds have the advantage of being close to public investors in terms of investor education, and also shoulder more direct investor protection and education responsibilities. Penghua Fund has been continuously guided by the needs of investors, focusing on combining the characteristics of different groups of people, and carrying out various and targeted investment and education activities, which have been recognized by the market and investors.
On the one hand, based on in-depth research, Penghua Fund has inspected high-quality companies, sought sustainable competitiveness of Chinese medicine enterprises, and explored the future development direction of the industry。 Since the beginning of 2023, Penghua Guoqu ETF investment and education activities have entered four listed Chinese medicine companies, and previously visited Guangzhou Pharmaceutical Baiyunshan, Jiuzhitang, Yunnan Baiyao, and Pien Tze Huang with investors to learn Chinese traditional culture up close and feel the innovative achievements of the transformation and upgrading of traditional Chinese medicine enterprises.
Investor protection doesn't happen overnight. Looking forward to the future, Penghua Fund will continue to uphold the concept of adhering to fundamental investment and paying close attention to holders, continue to improve the investment and education ecosystem of Penghua Guoqu ETF, and contribute to continuously improving investors' sense of gain and promoting the high-quality development of the public fund industry.
The activity of entering Taiji Group received enthusiastic feedback from investors, and the representative of the brokerage investment education base said:
Galaxy Securities: In April, join hands in investment education. On April 19, the Shanghai Stock Exchange-Penghua Fund Special Investment Education Taiji Group Station was successfully held. In the morning, the meeting visited the Fuling factory of Taiji Group, and effectively and deeply understood the corporate culture, positioning, and production process, during which the interaction was enthusiastic, and the on-site effect was full; in the afternoon, we visited the headquarters of Taiji Group, and saw a variety of rare Chinese medicinal materials, and also had a clearer understanding of the company's product line and development direction. Thanks to the Shanghai Stock Exchange and Penghua Fund for their careful organization, we look forward to the continuous development of the activities, work together to advance the concept of investment and education. I look forward to seeing you again next time!
Ms. Jiang Qian, deputy general manager and secretary of the board of directors of Taiji Group, fully and meticulously introduced the business situation and future development direction of Taiji Group, and patiently answered various questions from customers, pushing the atmosphere of the meeting to a climax!
Risk Warning: The above views only represent the personal views of the fund manager, do not represent the views of the fund manager, do not constitute actual investment advice, and do not represent the fund's past and future holdings. This information is only used for investor education and publicity of Penghua Fund. This information does not constitute any investment advice and should not be relied upon by investors as a substitute for their independent judgment or to make decisions based solely on such information. While we strive to ensure the accuracy and reliability of the information in this material, we do not guarantee the accuracy or completeness of such information and accept no liability for any loss arising from the use of such information. Funds are risky and should be invested with caution.